Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls
- PMID: 7586581
- DOI: 10.1016/0009-8981(95)06092-r
Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls
Abstract
Urinary macromolecules have attracted great interest because of their possible role as both promoters and inhibitors of calcium oxalate (CaOx) crystallization and it remains unclear whether there is any difference, in their nucleating activity, between stone formers and controls. We selected 9 male idiopathic CaOx stone formers whose 24-h urines presented no evidence of common urinary stone risk factors such as hypercalciuria, hyperoxaluria, hyperuricosuria, hypocitraturia, hypomagnesiuria or low glycosaminoglycans excretion and 12 male controls (matched for age and body weight) whose 24-h urines did not differ from those of stone formers. The study of urinary CaOx nucleation was made in freshly voided overnight urines whose biochemical composition was almost identical in the two groups. In filtered (0.22 micron) and ultrafiltered (10 kDa) urine we performed an oxalate tolerance test to determine the permissible increment of oxalate, the oxalate level for nucleation and the permissible increment of CaOx relative supersaturation (CaOx RS). In filtered urine from stone formers the permissible increment of oxalate was lower than controls (30 +/- 10.2 vs. 46.7 +/- 9.7 mg/l, P = 0.001), the oxalate level for nucleation was lower (64.4 +/- 14.2 vs. 79.5 +/- 15.6 mg/l, P = 0.035) and the permissible increment of CaOx RS was also lower (9.71 +/- 2.59 vs. 13.39 +/- 3.62, P = 0.018). In ultrafiltered urine these differences disappeared because the removal of macromolecules in stone formers significantly enhanced the oxalate-tolerance values. The difference between the change of the oxalate permissible increment of filtered and ultrafiltered urine allowed a distinction to be made between stone formers and controls that was not feasible in other ways (7.6 +/- 5.3 vs. 3.3 +/- 5.9 mg/l, P < 0.0001). The study suggests that, in idiopathic CaOx stone formers free from common urinary risk factors of CaOx crystallization, there is an increased tendency for CaOx nucleation in urine, which is mediated by macromolecular components.
Similar articles
-
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x. Kidney Int. 1999. PMID: 10027942
-
Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.Acta Biomed. 2002;73(1-2):11-26. Acta Biomed. 2002. PMID: 12233273
-
Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.Proc Eur Dial Transplant Assoc. 1983;20:440-4. Proc Eur Dial Transplant Assoc. 1983. PMID: 6197713
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research.Scanning Microsc. 1992 Sep;6(3):685-704; discussion 704-5. Scanning Microsc. 1992. PMID: 1439665 Review.
Cited by
-
The protection of polysaccharide from the Brown Seaweed Sargassum graminifolium against ethylene glycol-induced mitochondrial damage.Mar Drugs. 2013 Mar 13;11(3):870-80. doi: 10.3390/md11030870. Mar Drugs. 2013. PMID: 23528953 Free PMC article.
-
Effects of low-molecular-weight polyguluronate sulfate on experimental urolithiasis in rats.Urol Res. 2007 Dec;35(6):301-6. doi: 10.1007/s00240-007-0113-5. Epub 2007 Oct 11. Urol Res. 2007. PMID: 17929006
-
A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.Urol Res. 2011 Aug;39(4):231-43. doi: 10.1007/s00240-010-0349-3. Epub 2011 Jan 19. Urol Res. 2011. PMID: 21246193 Review.
-
The role of calcium phosphate in the development of Randall's plaques.Urolithiasis. 2013 Oct;41(5):369-77. doi: 10.1007/s00240-013-0602-7. Epub 2013 Aug 21. Urolithiasis. 2013. PMID: 23963104 Review.
-
Antioxidant properties of polysaccharide from the brown seaweed Sargassum graminifolium (Turn.), and its effects on calcium oxalate crystallization.Mar Drugs. 2012 Jan;10(1):119-130. doi: 10.3390/md10010119. Epub 2012 Jan 16. Mar Drugs. 2012. PMID: 22363225 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous